Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Latest News about Eli Lilly And Co

Recent news which mentions Eli Lilly And Co

< Previous 1 2 3 4 5 6 7 8 9
...
13 14 Next >
Telehealth company Ro launches GLP-1 supply tracker to help patients navigate shortages
Tags Health care industry Companies Health & Science
From CNBC.com News
This new weight loss drug ETF bets big on two of the industry's leading players
Tags Chugai Pharmaceutical Co Ltd Novo Nordisk A/S Personal investing
From CNBC.com News
How digital health companies are capitalizing on the GLP-1 boom
Tags Hospitals Mobile Technology
From CNBC.com News
Eli Lilly to invest another $5.3 billion in Indiana plant to expand Mounjaro, Zepbound supply
Tags Biotechnology Business Health care industry
From CNBC.com News
Cramer's Lightning Round: Sigma Lithium is 'too dicey'
Tags Investment Strategy Sony Group Corp Stock markets
From CNBC.com News
This up-and-coming cancer treatment could be a $25 billion market opportunity — it's already a hotbed for M&A
Tags Health & Science Health care industry Investing
From CNBC.com News
Healthy Returns: Eli Lilly, Novo Nordisk are competing to develop more convenient weekly insulins
Tags Health care industry Health & Science Science
From CNBC.com News
Roche says weight loss drug shows promising results in early trial
Tags Business News Novo Nordisk A/S Carmot Therapeutics Inc
From CNBC.com News
Healthy Returns: One in eight adults have taken Ozempic or other GLP-1s, survey says
Tags Alphabet Inc Science Novo Nordisk A/S
From CNBC.com News
People on Novo Nordisk's Wegovy maintain weight loss for up to four years, study says
Tags Health & Science Companies Health care industry
From CNBC.com News
Google's Demis Hassabis is the man tasked with turning bleeding-edge AI research into profits
Tags Eli Lilly and Co AI / Artificial Intelligence Tesla Inc
From CNBC.com News
Healthy Returns: Eli Lilly, Novo Nordisk make progress toward boosting weight loss drug supply
Tags Health care industry Health & Science Novo Nordisk A/S
From CNBC.com News
Amgen, newer rivals could threaten Novo Nordisk and Eli Lilly's weight loss drug dominance
Tags Novo Nordisk A/S Science Business
From CNBC.com News
Within a few years, generative AI will be designing new drugs all on its own
Tags Technology Executive Council NVIDIA Corp Drug trials
From CNBC.com News
Amgen stock soars on weight loss injection progress as Novo Nordisk, Eli Lilly shares slide
Tags US: News Pharmaceuticals Eli Lilly and Co
From CNBC.com News
Wegovy maker Novo Nordisk down 4%, heads for worst day since October
Tags Europe News LVMH Moet Hennessy Louis Vuitton SE Pharmaceuticals
From CNBC.com News
Amgen scraps experimental weight loss pill, moves forward with injection
Tags Eli Lilly and Co Pharmaceuticals US: News
From CNBC.com News
Eli Lilly beats on quarterly profit, hikes full-year guidance on strong sales of Zepbound, Mounjaro
Tags Business News Business Biotechnology
From CNBC.com News
5 things to know before the stock market opens Monday
Tags CVS Health Corp DoorDash Inc Investing
From CNBC.com News
Cramer's week ahead: Fed meeting and earnings from Apple, Amazon, Eli Lilly
Tags Stock Picks Investment strategy Markets
From CNBC.com News
Most people on weight loss drugs are spending less on restaurants and takeout, survey says
Tags US: News Morgan Stanley Sweetgreen Inc
From CNBC.com News
Most doses of Eli Lilly's Zepbound, Mounjaro in short supply through June, FDA says
Tags Health care industry Health & Science Companies
From CNBC.com News
Eli Lilly’s Zepbound shows promise as a sleep apnea treatment in late-stage trials
Tags Health care industry Companies Health & Science
From CNBC.com News
EU probe of weight loss and diabetes drugs like Wegovy, Ozempic finds no link to suicidal thoughts
Tags Health care industry Health & Science Companies
From CNBC.com News
Cramer says stocks that pulled back Tuesday still 'have everything going for them'
Tags Business Business News Stock markets
From CNBC.com News
Diabetes drug similar to Ozempic helped slow progression of Parkinson's disease in small trial
Tags Health & Science Companies Health care industry
From CNBC.com News
Healthy Returns: Weight loss, diabetes drug ad spending tops $1 billion
Tags AstraZeneca PLC Biotech and Pharmaceuticals Healthy Returns
From CNBC.com News
Altimmune says weight loss drug minimized muscle loss in trial results that may set it apart
Tags Novo Nordisk A/S Science Business
From CNBC.com News
Cramer says the market is broadening beyond the mega caps, reviews the S&P 500's hottest stocks
Tags Western Digital Corp Eli Lilly and Co Micron Technology Inc
From CNBC.com News
Viking Therapeutics stock jumps 15% on promising weight loss pill data
Tags Business Biotechnology Science
From CNBC.com News
< Previous 1 2 3 4 5 6 7 8 9
...
13 14 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.